[1]
T. Kistler and P. Ambühl, “Renal safety of combined cyclooxygenase 2 (COX-2) inhibitor and angiotensin II receptor blocker administration in mild volume depletion”, Swiss Med Wkly, vol. 131, no. 1314, pp. 193–198, Apr. 2001.